作者: Thomas Lake , Luke Esposito , Marisa-Claire Yadon , Franz F. Hefti , F. Michael Hudson
DOI:
关键词: Synuclein 、 Pathological 、 Disease 、 Preclinical imaging 、 Pathology 、 Medicine
摘要: Provided are the use of disclosed compounds as imaging agents and methods for in vivo detection pathological characteristics unique to synuclein diseases, such Parkinson's disease.